Instil Bio Inc. (TIL) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.99
• Market Cap: $57.99M
• EPS: $-11.35
• 52-Week High: $42.79
• 52-Week Low: $5.67

Market Sentiment

Instil Bio Inc. currently has a Neutral sentiment score of -0.13.

About Instil Bio Inc.

Instil Bio, Inc. is a clinical-stage biopharmaceutical company headquartered in Dallas, Texas, dedicated to pioneering advanced cell therapies for cancer treatment. The company is focused on developing its proprietary tumor-infiltrating lymphocyte (TIL) therapies, which are designed to enhance the immune system's ability to combat various malignancies. With a robust pipeline and a commitment to personalized immunotherapy, Instil Bio is strategically positioned to address significant unmet med...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Instil Bio Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TIL pay dividends?

Instil Bio Inc. (TIL) does not currently pay a regular dividend.

What is TIL's market cap?

Instil Bio Inc. (TIL) has a market capitalization of $57.99M with a current stock price of $8.99.